Filana Therapeutics (FLNA) Receivables - Net (2010 - 2020)

Filana Therapeutics (FLNA) posted quarterly Receivables - Net of $86000.0 for Q3 2020, down 62.77% quarter-over-quarter from $231000.0 in Q3 2011.

Filana Therapeutics (FLNA) Receivables - Net (2010 - 2020) Analysis & Trends

Filana Therapeutics' Receivables - Net history runs 3 years deep, the most recent figure standing at $86000.0 for Q3 2020.

In Q3 2020, Receivables - Net changed N/A year-over-year to $86000.0; the TTM figure through Sep 2020 stood at $86000.0 (changed N/A YoY), while the FY2010 annual figure was $7.1 million, changed N/A from the prior year.
Receivables - Net for Q3 2020 stood at $86000.0, down from $231000.0 in the prior quarter.
The five-year high for Receivables - Net was $86000.0 in Q3 2020, with the low at $86000.0 in Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Filana Therapeutics	46.00 Mn	46.00 Mn	-

Download Data